Medprin Regenerative Medical Technologies Co. Ltd. Asset Resilience Ratio

Latest as of June 2025: 19.31%

Medprin Regenerative Medical Technologies Co. Ltd. asset resilience ratio. Medprin Regenerative Medical Technologies Co. Ltd. (301033) has an Asset Resilience Ratio of 19.31% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Medprin Regenerative Medical Technologie to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥155.45 Million
≈ $22.75 Million USD Cash + Short-term Investments

Total Assets

CN¥805.10 Million
≈ $117.81 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)

Asset resilience ratio of Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024. This chart shows how Medprin Regenerative Medical Technologies Co. Ltd.'s Asset Resilience Ratio has changed over time. Read Medprin Regenerative Medical Technologie balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Medprin Regenerative Medical Technologies Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 301033 total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥155.45 Million 19.31%
Total Liquid Assets CN¥155.45 Million 19.31%

Asset Resilience Insights

  • Good Liquidity Position: Medprin Regenerative Medical Technologies Co. Ltd. maintains a healthy 19.31% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Medprin Regenerative Medical Technologies Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Medprin Regenerative Medical Technologies Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Applied BioCode
TW:6598
Medical Devices 9.75%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Radiant Innovation
TWO:3373
Medical Devices 0.82%
Impedimed Ltd
AU:IPD
Medical Devices 46.15%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Medprin Regenerative Medical Technologies Co. Ltd. Asset Resilience Ratio by Year (2019–2024)

Medprin Regenerative Medical Technologies Co. Ltd. asset resilience ratio by year from 2019 to 2024. The table below shows the annual Asset Resilience Ratio data for Medprin Regenerative Medical Technologies Co. Ltd..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 17.25% CN¥137.85 Million
≈ $20.17 Million
CN¥799.23 Million
≈ $116.95 Million
-7.25pp
2023-12-31 24.50% CN¥192.82 Million
≈ $28.22 Million
CN¥786.97 Million
≈ $115.16 Million
+4.76pp
2022-12-31 19.74% CN¥147.07 Million
≈ $21.52 Million
CN¥744.92 Million
≈ $109.01 Million
-30.55pp
2021-12-31 50.29% CN¥375.57 Million
≈ $54.96 Million
CN¥746.78 Million
≈ $109.28 Million
+6.51pp
2020-12-31 43.78% CN¥199.33 Million
≈ $29.17 Million
CN¥455.34 Million
≈ $66.63 Million
-1.15pp
2019-12-31 44.93% CN¥152.77 Million
≈ $22.36 Million
CN¥340.05 Million
≈ $49.76 Million
--
pp = percentage points

About Medprin Regenerative Medical Technologies Co. Ltd.

SHE:301033 China Medical Devices
Market Cap
$523.93 Million
CN¥3.58 Billion CNY
Market Cap Rank
#11691 Global
#3288 in China
Share Price
CN¥53.40
Change (1 day)
+2.06%
52-Week Range
CN¥45.16 - CN¥81.00
All Time High
CN¥88.80
About

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a S… Read more